Clinical trial
Fecal Microbial Transplantation in Patients With Medication Refractory Clostridium Difficile and/or Ulcerative Colitis or Indeterminate Colitis
NCT03268213 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fecal Microbial Transplantation in Patients With Medication Refractory Clostridium Difficile and/or Ulcerative Colitis or Indeterminate Colitis
- Lead sponsor
- Stony Brook University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- February 15, 2022
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clostridium difficile infection, indeterminate colitis, ulcerative colitis